Rehni et al., Naunyn Schmiedebergs Arch Pharmacol 2012
(Opioid-Related Disorders...) :
The present study has been designed to investigate the effect of selective inhibitors of histone deacetylase and/or N-acetyl-Asp-Glu-Val-Asp-al ( Ac-DEVD-CHO ), a selective interleukin-1ß converting enzyme inhibitor , on the development of naloxone induced opioid withdrawal syndrome both in vitro and in vivo and the effect of histone deacetylase inhibition on histone H3 acetylation in brain
Goswami et al., J Immunol 2012
:
Inhibition of histone deacetylase activity augments PU.1 dependent IL-9 production